Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kyle T. Matschke"'
Autor:
Rajinder Bhardwaj, Mary K. Donohue, Jennifer Madonia, Beth Morris, Thomas C. Marbury, Kyle T. Matschke, Robert Croop, Richard Bertz, Jing Liu
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract Zavegepant, a high‐affinity, selective, small‐molecule calcitonin gene‐related peptide (CGRP) receptor antagonist, is approved in the United States for acute treatment of migraine in adults. The effects of moderate hepatic impairment (
Externí odkaz:
https://doaj.org/article/7633456a305843bd910ec34af3475719
Autor:
Rajinder Bhardwaj, Michael S. Hanna, Beth A. Morris, Kyle T. Matschke, Richard Bertz, Robert S. Croop, Jing Liu
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 3, Pp n/a-n/a (2024)
Abstract A single‐center, phase I, partially double‐blind (double‐blind regarding doses of rimegepant and placebo, and open label with respect to moxifloxacin), randomized, 12‐sequence, four‐period crossover study of therapeutic (75 mg) and
Externí odkaz:
https://doaj.org/article/b30d7f9d6f584fa8a3848a5c2e88b521
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Background: Abuse of prescription opioids, particularly by intravenous (IV) administration, can cause respiratory depression and death. ALO-02, an abuse-deterrent opioid formulation, is designed to release sequestered naltrexone upon manipulation by
Externí odkaz:
https://doaj.org/article/e4280abc13a748d0adc00eb6928d629e